Jaguar health announces import of coca leaf from peru by joint venture magdalena biosciences for research in treating mental health indications

Magdalena to explore coca leaf's possible therapeutic benefit for treatment of potentially adhd or other neuropsychiatric indications the import was conducted in collaboration with the government of peru steven king, ph.d. of jaguar to speak about the potential promise of coca-based botanical drugs at the february 2025 wisdom of the leaf coca summit in peru magdalena is focused on developing novel, natural prescription medicines derived from plants for mental health indications san francisco, ca / accesswire / december 19, 2024 / jaguar health, inc. (nasdaq:jagx) ("jaguar") today announced that magdalena biosciences, inc. ("magdalena"), a joint venture formed by jaguar and filament health corp. (otcqb:flhlf)(cboe ca:fh)(fse:7qs) ("filament" or "filament health"), successfully completed an import of six kilograms of coca leaf from peru to filament's metro vancouver research and development facility.
JAGX Ratings Summary
JAGX Quant Ranking